|
Re: BETonMACE Placebo Estimate
|
3
|
Resverlogix Corp.
|
Feb 20, 2019 01:19PM
|
|
Re: Why is pps where it is
|
3
|
Resverlogix Corp.
|
Feb 23, 2020 09:42AM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
3
|
Resverlogix Corp.
|
Jun 02, 2022 02:21PM
|
|
Re: Tundup's message
|
3
|
Resverlogix Corp.
|
Apr 14, 2019 10:09AM
|
|
Re: Checking the chart and seeing another pennant, contractions coming quicker....
|
3
|
Resverlogix Corp.
|
May 12, 2019 09:15AM
|
|
Re: Trading
|
3
|
Zenith Epigenetics
|
Sep 20, 2022 03:01PM
|
|
Re: Zenith a Loser Too
|
3
|
Resverlogix Corp.
|
Jun 16, 2020 01:00PM
|
|
Re: Your thoughts please
|
3
|
Resverlogix Corp.
|
Sep 08, 2024 07:30AM
|
|
Re: Covid PIII Questions and Thoughts
|
3
|
Resverlogix Corp.
|
May 24, 2022 04:01PM
|
|
Re: One More Promissory Note-Aug 9/24
|
3
|
Zenith Epigenetics
|
Sep 08, 2024 07:41AM
|
|
Re: Nice run for Hepa over the holidays
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 02:10PM
|
|
Shorters have not cashed out yet!
|
3
|
Resverlogix Corp.
|
Feb 10, 2022 11:11AM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
3
|
Resverlogix Corp.
|
Oct 04, 2023 11:41AM
|
|
Re: In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 09:25AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 11:57AM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
3
|
Resverlogix Corp.
|
Jul 16, 2019 01:13PM
|
|
Exempt Distribution - November 16, 2022
|
3
|
Zenith Epigenetics
|
Dec 06, 2022 12:32PM
|
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 17, 2021 09:20AM
|
|
Re: What we know and what we don't.....
|
3
|
Resverlogix Corp.
|
May 16, 2019 03:55PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 20, 2023 10:03AM
|
